{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:27Z","timestamp":1790870487500,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.nucmedbio.2008.04.010","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T06:23:50Z","timestamp":1214893430000},"page":"665-671","source":"Crossref","is-referenced-by-count":14,"title":["The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR"],"prefix":"10.1016","volume":"35","author":[{"given":"Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2008.04.010_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics CA","volume":"49","author":"Parkin","year":"1999","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer statistics, 2000 CA","volume":"50","author":"Greenlee","year":"2000","journal-title":"Cancer J Clin"},{"issue":"7","key":"10.1016\/j.nucmedbio.2008.04.010_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF02897458","article-title":"An analysis of cancer incidence and mortality from 30 cancer registries in China, 1998\u20132002","volume":"15","author":"Zhang","year":"2005","journal-title":"Bull Chin Cancer"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiology.219.3.r01jn28785","article-title":"Fine-needle aspiration biopsy of nonpalpable lesions in a multicenter clinical trial: results from the Radiologic Diagnostic Oncology Group V","volume":"219","author":"Pisano","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0960-9776(03)00102-4","article-title":"Fine-needle aspiration cytology in nonpalpable mammographic abnormalities in breast cancer screening","volume":"12","author":"Sauer","year":"2003","journal-title":"Breast"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","article-title":"Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates","volume":"218","author":"Jackman","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib7","first-page":"225","article-title":"Tc-99m tetrofosmin mammoscintigraphy: a prospective study in primary breast lesions","volume":"35","author":"Lind","year":"1996","journal-title":"Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00006231-200302000-00007","article-title":"The usefulness of Tc-99m tetrofosmin scintigraphy in patients with breast cancer recurrences","volume":"24","author":"Spanu","year":"2003","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0001-2998(98)80034-2","article-title":"PET in breast cancer","volume":"28","author":"Flanagan","year":"1998","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1095-0397(99)00032-1","article-title":"Utility of PET in breast cancer","volume":"2","author":"Avril","year":"1999","journal-title":"Clin Positron Imag"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib11","first-page":"245","article-title":"PET imaging in breast cancer","volume":"43","author":"Bombardieri","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1095-0397(01)00069-3","article-title":"FDG PET in breast cancer: a different view of its clinical use","volume":"4","author":"Czernin","year":"2002","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0960-9776(02)00262-X","article-title":"Comparison of FDG PET and dynamic contrast enhanced MRI in the evaluation of suggestive breast lesions","volume":"12","author":"Heinisch","year":"2003","journal-title":"Breast"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib14","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1210\/jc.80.10.2974","article-title":"Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma","volume":"80","author":"Vikic-Topic","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1014972520302","article-title":"True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5","volume":"72","author":"Schulz","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(94)92637-9","article-title":"Somatostatin-receptor scintigraphy in primary breast cancer","volume":"343","author":"van Eijck","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/snuc.2002.31022","article-title":"Somatostatin receptor imaging","volume":"32","author":"Kwekkeboom","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib19","doi-asserted-by":"crossref","unstructured":"Mezi S, Primi F, Orsi E, et al. Somatostatin Scintigraphy in the metastatic breast cancer patients. Oncol Rep 2005;13:31\u201335.","DOI":"10.3892\/or.13.1.31"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00259-002-1107-8","article-title":"Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002","volume":"30","author":"de Jong","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/snuc.2002.31027","article-title":"Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings","volume":"32","author":"de Jong","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ijc.10952","article-title":"Anti-tumor effect and increased survival after treatment with [177Lu-DOTA0,Tyr3] octreotate in a rat liver micrometastases model","volume":"104","author":"Breeman","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib23","first-page":"610","article-title":"Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq 90Y-DOTATOC","volume":"43","author":"Waldherr","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1011160913619","article-title":"The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study","volume":"12","author":"Waldherr","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.2967\/jnumed.107.040824","article-title":"The role of technetium-99m sandostatin scintigraphy in suspected lung cancer compared with 18F-FDG dual head coincidense imaging","volume":"48","author":"Wang","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2<259::AID-IJC14>3.0.CO;2-7","article-title":"Induction of wild-type p53 Bax and acidic endonuclease during somatostatin signaled apoptosis in MCF-7 human breast cancer cells","volume":"76","author":"Sharma","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2001.01175.x","article-title":"Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid","volume":"54","author":"Papotti","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib28","first-page":"6","article-title":"Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy","volume":"47","author":"Van Den Bossche","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00259-007-0587-y","article-title":"68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors","volume":"51","author":"Pettinato","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","article-title":"Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?","volume":"34","author":"Antunes","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2008.04.010_bib31","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labeling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T08:09:00Z","timestamp":1557648540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805108001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0969805108001078"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2008.04.010","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}